共 50 条
- [1] Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 947 - 955
- [2] Erlotinib in non-small-cell lung cancer [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (15) : 2579 - 2592
- [3] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2367 - 2367
- [4] NICE guidance on erlotinib for the maintenance treatment of non-small-cell lung cancer [J]. LANCET ONCOLOGY, 2011, 12 (08): : 728 - 730
- [5] Special Report: Policy Erlotinib for the treatment of non-small-cell lung cancer [J]. LANCET ONCOLOGY, 2009, 10 (01): : 15 - 16
- [6] Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer [J]. LUNG CANCER-TARGETS AND THERAPY, 2011, 2 : 1 - 9
- [8] Erlotinib As Maintenance Monotherapy in Non-Small-Cell Lung Cancer [J]. BIODRUGS, 2011, 25 (03) : 139 - 146
- [9] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer REPLY [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2368 - 2368
- [10] Erlotinib in previously treated non-small-cell lung cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 123 - 132